Wall Street JournalEN
C
CSCI
COSCIENS
4.02
0.000.00%Opening09:30 02/05 EST
OPEN/PREV CLOSE--/4.020
TODAY RANGE-
VOL202
MARKET CAP15.18M
52 WEEK RANGE3.500-15.13
AVG VOL (3M)2.58K
% TURNOVER0.01%
TURNOVER--
P/E (TTM)-0.3812
% RANGE--
EPS(TTM)-10.5447
P/E(FORWARD)-0.8330
P/B0.463
BVPS8.67
DIVIDEND--
P/S0.819
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP14.98M
SHARES OUTSTANDING3.78M
NEXT EARNINGS--
FREE FLOAT3.73M
LOT SIZE100
EX-DIV DATE06/03/2024
News
Press Releases
Financial Reports
Profile
Dow Jones·10/08/2024 11:31
*COSCIENS Biopharma: Carolyn Egbert Resigns From Bd of Directors
Dow Jones·09/23/2024 14:57
Cosciens Biopharma Shares Fall on ALS Treatment Research End, Cost Cutting
Dow Jones·09/23/2024 11:32
*COSCIENS Biopharma Eliminating Number of Managerial and Technical Positions >CSCI
Dow Jones·09/23/2024 11:32
*COSCIENS Biopharma Reducing the Spend on Certain Programs Pending Completion of Data Review >CSCI
Dow Jones·09/23/2024 11:31
*COSCIENS Biopharma: Board Has Engaged Executive Recruiting Firm to Identify Next Pres and CEO >CSCI
Dow Jones·08/27/2024 14:09
Cosciens Biopharma Shares Drop After Trial Misses Key Target
Dow Jones·08/27/2024 11:57
Cosciens Biopharma Study of Macimorelin for Children Misses Primary Efficacy Endpoint
Dow Jones·08/13/2024 12:08
*COSCIENS Biopharma 2Q Loss/Shr 64c >CSCI
Dow Jones·08/13/2024 12:07
*COSCIENS Biopharma 2Q Rev $2.3M >CSCI
Dow Jones·06/07/2024 21:08
*News On Ceapro Inc. (CZO.V) Now Under AEZS.T
Dow Jones·05/14/2024 22:01
*AEterna Zentaris 1Q Loss/Shr $4.74 >AEZS
Dow Jones·03/28/2024 11:56
*AEterna Zentaris and Ceapro Anticipate Completing the Transaction in the 2Q of 2024 >AEZS
Dow Jones·03/28/2024 11:55
*Ceapro Receives Final Court Approval For Merger With Aeterna Zentaris AEZS
Dow Jones·03/12/2024 18:10
*Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others